Insulet (Nasdaq:PODD) announced today that it appointed Flavia Pease to succeed Ana Maria Chadwick as EVP and CFO.

BD (NYSE:BDX) announced that it expanded its Class I voluntary recall for its Alaris Pump Module model 8100 infusion system.

Dexcom (Nasdaq:DXCM) today announced plans to unveil its Smart Basal integrated titration module for insulin delivery.

The FDA identified a recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors as the most serious type.

Teleflex (NYSE:TFX) announced today that it enrolled the first patient in its DUBSTENT DIABETES trial. The randomized, ...

Insulet (Nasdaq:PODD) has its eyes on future expansion in new geographies, according to some of its leading executives.

Elutia announced today that it agreed to sell its bioenvelope technologies to Boston Scientific for $88 million.

Dexcom (Nasdaq:DXCM) filed with the state of California to confirm plans to lay off more than 300 employees in San Diego.

The NHS announced a first-of-its-kind initiative in England, offering automated insulin delivery systems for pregnant women ...

Utrecht, The Netherlands-based ViCentra plans to use the funds to accelerate manufacturing scale, launch its next-generation ...

Senseonics announced that it entered into an agreement with Diabetes Care to take over commercialization efforts for its ...

Ypsomed announced that the FDA granted 510(k) clearance for SmartPilot, a digital connectivity add-on for its Ypsomate ...